Study | Reason for exclusion |
---|---|
Golabi 2006 | Four weeks of treatment, only tiotropium alone and salmeterol/fluticasone treatment groups, cross‐over design |
Hara 2007 | Eight weeks of treatment, only tiotropium alone and salmeterol/fluticasone treatment groups, cross‐over design |
Mittmann 2010 | No tiotropium plus LABA treatment group |
Singh 2008 | Two weeks of treatment, no tiotropium plus LABA treatment group, and of cross‐over design |